Randomised controlled trial
Single HPV test not useful for predicting CIN2 or worse or for guiding choice of further investigations for women aged 20–59 presenting to NHS Cervical Screening Programme with borderline abnormalities or mild dyskaryosis
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.